(4-Methyl-2-oxo-2H-chromen-7-yloxy)-acetic acid, 97%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-2-methylpent-4-enoic acid, 98%, 250mg

1-Benzyl-1,4-diazepan-5-one hydrochloride, 97.0%, 5g

2-Fluoro-4-(4-methylpiperazin-1-yl)benzaldehyde, 95.0%, 1g

2-Bromo-1-fluoro-4-methoxybenzene, 95.0%, 500g

2-(Phenylcarbamoyl)benzoic Acid>95.0%(HPLC)(T)5g

3-Iodo-2-methylpyridine, 95.0%, 250mg

SULFANITRAN, 98%, 250mg

Ácido 3-bromobenzoico, mínimo 99 %, para síntesis, 25 g, envase de vidrio

(5-Fluoro-2-(hydroxymethyl)phenyl)boronic acid, 95.0%, 10g

2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-glucopyranosyl chloride, 25g

4,4'-Di-tert-butylbenzophenone, 97.0%, 100mg

2-Hydroxyphenylacetic Acid>98.0%(GC)(T)25g